Alnylam Pharmaceuticals
ALNY
#814
Rank
โ‚ฌ27.37 B
Marketcap
204,62ย โ‚ฌ
Share price
0.23%
Change (1 day)
-47.11%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company